Genedata AG Mar 11 2026 Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that mAbxience has selected the Genedata Bioprocess ® enterprise platform to structure and harmonize all bioprocess development data across its operations. mAbxience, majority-owned by the Fresenius Kabi group, is a global Contract Development and Manufacturing Organization (CDMO) specializing in the manufacture of biosimilars. "With our